Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,476 | 23,368 | 18,520 | 29,688 | 8,761 |
| TOTAL | $14,683 | $23,700 | $18,924 | $31,404 | $8,762 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 820 | 0 | 0 | 0 | 0 |
| TOTAL | $820 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $15,503 | $23,700 | $18,924 | $31,404 | $8,762 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,283 | 3,849 | 3,520 | 510 | 1,008 |
| Accrued Expenses | 7,359 | 12,925 | 6,143 | 1,835 | 325 |
| TOTAL | $14,602 | $17,175 | $9,962 | $2,345 | $1,333 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 89 | 807 | 567 | 373 | 1,964 |
| TOTAL | $89 | $807 | $567 | $373 | $1,964 |
| Total Liabilities | $14,691 | $17,982 | $10,529 | $2,718 | $3,297 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,740 | 27,919 | 20,452 | 15,133 | 9,232 |
| Common Shares | 5 | 3 | 2 | 1 | 1 |
| Retained earnings | -164,273 | -134,354 | -95,093 | -66,832 | -58,310 |
| TOTAL | $813 | $5,719 | $8,394 | $28,687 | $5,466 |
| Total Liabilities And Equity | $15,503 | $23,700 | $18,924 | $31,404 | $8,762 |